Back to results
US 12,465,619 B2Granted
Use of polar lipids to treat or prevent gestational diabetes mellitus
AssigneeFonterra Co-Operative Group Limited
InventorsSophie Yvette Fabienne Christine Gallier, Angela Marie Rowan, Philip Newton Baker
Life of this patent
Estimating the term…
Abstract
Methods of treating or preventing gestational diabetes mellitus (GDM) and/or treating or preventing one or more GDM-associated risks or one or more sequelae of GDM by administering one or more polar lipids, in addition to uses, compositions, and medicaments comprising one or more polar lipids to treat or prevent gestational diabetes mellitus and/or treat or prevent one or more GDM-associated risks or one or more sequelae of GDM.
Claims14
A method of reducing the risk of gestational diabetes mellitus (GDM) in a pregnant subject in need thereof comprising:
- administering daily at least 0.2 g of polar lipids derived from non-human mammalian milk for a minimum period of from 14 weeks to 22 weeks gestation, wherein the polar lipids comprise one or more phospholipids and one or more gangliosides.
Dependencies are inferred from the claim text.